ARCHIVES

An “insurgency” targets randomized trials, demands access to investigational drugs.

This article is from The Cancer Letter archive.

Vol. 31 No. 31 | August 5, 2005

Download PDF Visit The Full Archive

Related Articles

NCI May Ask Grantees To Assume Additional Services, Broder Says

November 11, 1994

DRCCA Board Cool On communications Network, Hears Report On Behavior Program

May 21, 1982

Guest Editorial – Interlocking Tragedies: Lance Armstrong and CPRIT

February 15, 2013

In Brief: Nurses Association Endorses Clinton-Gore; Levin Heads New Society For Neuro-Oncology

June 28, 1996

FDA, ASCO Meet to Review Drug Approval Endpoints

April 25, 2003

ASCO Guidelines On CSFs Call For Use In Fewer Patients

December 2, 1994